Johnson & Johnson Family of Companies: Australia
Dec 23, 2024 · Johnson & Johnson Pacific Pty Ltd (JJP) touches millions of people’s lives every day. Many of our products are household names. In fact, you’ll find a JJP product in 7-out-of-10 Australian homes. We’re the largest over-the-counter supplier to retail Pharmacy in the country. We serve over 4,500 community pharmacies.
Introducing Johnson & Johnson Innovative Medicine | Home
Sep 19, 2024 · The Janssen Pharmaceutical Companies of Johnson & Johnson is now Johnson & Johnson Innovative Medicine. Learn who we are and what our purpose is—leading where medicine is going.
Johnson & Johnson Single-Dose COVID-19 Vaccine ... - Janssen …
The Johnson & Johnson COVID-19 single-dose vaccine is compatible with standard vaccine storage and distribution channels enabling delivery to remote areas. The vaccine is estimated to remain stable for two years at -25°C to -15°C, and a maximum of three months of which can be at routine refrigeration at temperatures of 2°C -8°C.
J&J Innovative Medicine | 2023 U.S. Pricing Transparency Report
Johnson & Johnson Innovative Medicine's eighth U.S. Pricing Transparency Report provides key data, analysis, and insights to help advance solutions to create a more sustainable, equitable, and innovative healthcare system.
Janssen In Hong Kong
In 1961, Janssen Pharmaceutica joined the Johnson & Johnson Family of Companies. Today, even as our company has grown and evolved to serve the changing needs of our patients and the healthcare industry, we are still guided by Dr Janssen’s values of excellence and innovation.
Coronavirus (Covid-19): Patient Resources - Janssen United States
As the pharmaceutical companies of Johnson & Johnson, we are part of a large family of companies that has the unique ability to leverage our deep scientific expertise and extensive partnerships to help in the fight against COVID-19.
ヤンセンファーマ株式会社、日本において Johnson & Johnson ブ …
Jul 1, 2024 · 米Johnson & Johnson（J&J）グループの日本における医療用医薬品事業を担うヤンセンファーマ株式会社（本社：東京都千代田区、代表取締役社長：關口修平）は2024年7月1日より、「Johnson & Johnson」ブランドの対外使用を開始し、国内における医療用医薬品事業を ...
Johnson & Johnson Announces Expansion of IMBRUVICA
(February 26, 2024) – Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced today that the U.S. Food and Drug Administration (FDA) has approved a label expansion for IMBRUVICA ® (ibrutinib) with an oral suspension formulation for adult patients in the treatment of chronic lymphocytic ...
Contact Janssen Australia
Dec 23, 2024 · Customer Service - for wholesaler or pharmacy enquiries related to Janssen medicines:
Janssen | 2022 Transparency Report
In this report, we refer to locations where you can find more information about specific Janssen U.S. and Johnson & Johnson programs, disclosures, and patient resources.